A mutation within the saposin D domain in a Gaucher disease patient with normal glucocerebrosidase activity
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Only two Gaucher disease (GD) patients bearing mutations in the prosaposin gene (PSAP), and not in the glucocerebrosidase gene (GBA), have been reported. In both cases, one mutant allele remained unidentified. We report here the identification of the second mutation in one of these patients, being the first complete genotype described so far in a SAP-C-deficient GD patient. This mutation, p.Q430X, is the first one reported in the saposin D domain and probably produces a null allele by nonsense mediated mRNA decay.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Genetic PSAP deficiency in humans also causes various forms of progressive neurodegenerative conditions depending on the type of mutation in the PSAP gene (48–51).”
From Treatment of a genetic brain disease by CNS-wide microglia replacement (2022) · cites this paper as [50]
In the citing paper
“Given the unique vulnerability of neurons to redox imbalance-induced oxidative stress, which is often found in the brain of patients with neurodegenerative diseases25–29, we sought to apply our functional genomics toolkit to systematically identify factors that are important for redox homeostasis and oxidative stress response in human neurons.”
From Genome-wide CRISPRi/a screens in human neurons link lysosomal failure to ferroptosis (2021) · cites this paper as [29]
Citations
Cites
Nagy, E., & Maquat, L. E. (1998) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01208-0 · Cited by 1,187
Mutation in the sphingolipid activator protein 2 in a patient with a variant of Gaucher disease
Schnabel, D., Schröder, M., & Sandhoff, K. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80760-z · Cited by 162
Christomanou, H., Aignesberger, A., & LINKE, R. P. (1986) · Biological Chemistry Hoppe-Seyler · doi:10.1515/bchm3.1986.367.2.879 · Cited by 154
Activator protein deficient Gaucher's disease
Christomanou, H., Amparo Chabás, B., Pàmpols, T., & Guardiola, A. (1989) · Journal of Molecular Medicine · doi:10.1007/bf01716064 · Cited by 100
Mutational analysis in a patient with a variant form of Gaucher disease caused by SAP-2 deficiency
Rafi, M. A., de Gala, G., Zhang, X.-L., & Wenger, D. A. (1993) · Somatic Cell and Molecular Genetics · doi:10.1007/bf01233949 · Cited by 86
Pàmpols, T., Pineda, M., Girós, M., Ferrer, I., Cusí, V., Amparo Chabás, B., Sanmartí, F., Vanier, M. T., & Christomanou, H. (1999) · Acta Neuropathologica · doi:10.1007/s004010050960 · Cited by 58
Molecular and cell biology of acid β-glucosidase and prosaposin
Qi, X., & Grabowski, G. A. (2000) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(00)66030-0 · Cited by 37
Cited by
Genome-wide CRISPRi/a screens in human neurons link lysosomal failure to ferroptosis
Tian, R., Abarientos, A., Hong, J., Hashemi, S. H., Yan, R., Dräger, N., Leng, K., Nalls, M. A., Singleton, A. B., Xu, K., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00862-0 · Cited by 414
Genome-wide CRISPRi/a screens in human neurons link lysosomal failure to ferroptosis
Tian, R., Abarientos, A., Hong, J., Hashemi, S. H., Yan, R., Dräger, N., Leng, K., Nalls, M. A., Singleton, A. B., Xu, K., et al. (2020) · doi:10.1101/2020.06.27.175679 · Cited by 414
Sphingolipid metabolism diseases
Kolter, T., & Sandhoff, K. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.05.027 · Cited by 367
“A recent work [227] demonstrated a Q430X mutation in the Sap-D-domain on the other allele, so that at least one of the patients is compound heterozygote for Sap-C- and prosaposin deficiency.”
BackgroundLysosomal dysfunction in neurodegeneration: emerging concepts and methods
Udayar, V., Chen, Y., Sidransky, E., & Jagasia, R. (2022) · Trends in Neurosciences · doi:10.1016/j.tins.2021.12.004 · Cited by 240
Multi-system disorders of glycosphingolipid and ganglioside metabolism
Xu, Y.-H., Barnes, S., Sun, Y., & Grabowski, G. A. (2010) · Journal of Lipid Research · doi:10.1194/jlr.r003996 · Cited by 166
Metadata
- Authors
- Diaz-Font, A., Cormand, B., Santamaria, R., Vilageliu, L., Grinberg, D., & Chabás, A.
- Affiliations
- Universitat de Barcelona (ES)
- Corresponding author
- Grinberg, Daniel
- Venue
- Human Genetics
- Published
- 2005-04-23
- Volume
- 117
- Issue
- 2-3
- Pages
- 275-277
- ISSN
- 0018-7348 (ISSN-L)
- 0340-6717
- 1432-1203
- OpenAlex
- W1983019146
- Cited by
- 48
- References
- 7
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 3 · 2022: 3 · 2021: 2 · 2020: 4 · 2019: 2 · 2018: 2 · 2017: 2 · 2016: 1 · 2015: 2 · 2014: 4 · 2013: 2 · 2012: 4
- FWCI
- 1.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Human Genetics (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- Gaucher disease, saposin D, nonsense mutation, null alleles, nonsense-mediated mRNA decay, genotype identification
- MeSH terms
- Brain, Brain Chemistry, Exons, Gaucher Disease, Glucosylceramidase, Humans, Point Mutation, RNA Stability, Saposins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A mutation within the saposin D domain in a Gaucher disease patient with normal glucocerebrosidase activity. https://app.cochat.ai/papers/10.1007/s00439-005-1288-x
- The paper
- Diaz-Font, A., Cormand, B., Santamaria, R., Vilageliu, L., Grinberg, D., & Chabás, A. (2005). A mutation within the saposin D domain in a Gaucher disease patient with normal glucocerebrosidase activity. Human Genetics. https://doi.org/10.1007/s00439-005-1288-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.